Olfactomedin 4 as a circulating biomarker for asthma.
作者信息
Jang An-Soo
机构信息
Department of Internal Medicine, Soonchunhyang University, Bucheon Hospital, Bucheon, Korea.
出版信息
Ann Transl Med. 2022 Oct;10(20):1085. doi: 10.21037/atm-22-3983.
Abstract
摘要
相似文献
1
Olfactomedin 4 as a circulating biomarker for asthma.嗅觉介质蛋白4作为哮喘的循环生物标志物
Ann Transl Med. 2022 Oct;10(20):1085. doi: 10.21037/atm-22-3983.
2
Serum levels of olfactomedin 4: a biomarker for asthma control state in asthmatics.嗅觉介素4的血清水平：哮喘患者哮喘控制状态的生物标志物
Ann Transl Med. 2020 Apr;8(7):494. doi: 10.21037/atm.2020.03.213.
3
The clinical significance and biological function of olfactomedin 4 in triple negative breast cancer.嗅鞘蛋白 4 在三阴性乳腺癌中的临床意义和生物学功能。
Biomed Pharmacother. 2017 Feb;86:67-73. doi: 10.1016/j.biopha.2016.11.081. Epub 2016 Dec 7.
4
Serum olfactomedin 4 (GW112, hGC-1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients.血清嗅鞘蛋白4（GW112，hGC-1）与Reg IV联合检测是胃癌患者的一种高灵敏度生物标志物。
Int J Cancer. 2009 Nov 15;125(10):2383-92. doi: 10.1002/ijc.24624.
5
Olfactomedin-4 is a candidate biomarker of solid gastric, colorectal, pancreatic, head and neck, and prostate cancers.嗅觉介质蛋白4是实体胃癌、结直肠癌、胰腺癌、头颈癌和前列腺癌的一种候选生物标志物。
Proteomics Clin Appl. 2015 Feb;9(1-2):58-63. doi: 10.1002/prca.201400083. Epub 2014 Dec 28.
6
Olfactomedin 4 (GW112, hGC-1) is an independent prognostic marker for survival in patients with colorectal cancer.嗅觉介质蛋白4（GW112，hGC-1）是结直肠癌患者生存的独立预后标志物。
Exp Ther Med. 2010 Jan;1(1):73-78. doi: 10.3892/etm_00000013. Epub 2010 Jan 1.
7
Evolution of olfactomedin. Structural constraints and conservation of primary sequence motifs.嗅觉介质的进化。一级序列基序的结构限制与保守性。
Ann N Y Acad Sci. 1998 Nov 30;855:294-300. doi: 10.1111/j.1749-6632.1998.tb10585.x.
8
A multidomain TIGR/olfactomedin protein family with conserved structural similarity in the N-terminal region and conserved motifs in the C-terminal region.一个多结构域的TIGR/嗅觉介质蛋白家族，在N端区域具有保守的结构相似性，在C端区域具有保守基序。
Mol Cell Proteomics. 2002 May;1(5):394-403. doi: 10.1074/mcp.m200023-mcp200.
9
10
Olfactomedin domain-containing proteins: possible mechanisms of action and functions in normal development and pathology.含嗅觉介质结构域的蛋白质：在正常发育和病理学中的可能作用机制及功能
Mol Neurobiol. 2009 Oct;40(2):122-38. doi: 10.1007/s12035-009-8076-x. Epub 2009 Jun 26.
本文引用的文献
1
CCL4 Functions as a Biomarker of Type 2 Airway Inflammation.四氯化碳作为2型气道炎症的生物标志物发挥作用。
Biomedicines. 2022 Jul 23;10(8):1779. doi: 10.3390/biomedicines10081779.
2
Analysis of cell-specific peripheral blood biomarkers in severe allergic asthma identifies innate immune dysfunction.重度过敏性哮喘患者细胞特异性外周血生物标志物分析揭示先天性免疫功能障碍。
Clin Exp Allergy. 2022 Nov;52(11):1334-1337. doi: 10.1111/cea.14197. Epub 2022 Aug 2.
3
Diagnostic Accuracy of Liquid Biomarkers in Airway Diseases: Toward Point-of-Care Applications.气道疾病中液体生物标志物的诊断准确性：迈向即时护理应用
Front Med (Lausanne). 2022 Jun 6;9:855250. doi: 10.3389/fmed.2022.855250. eCollection 2022.
4
Neutrophils and Asthma.中性粒细胞与哮喘
Diagnostics (Basel). 2022 May 8;12(5):1175. doi: 10.3390/diagnostics12051175.
5
Recent patents in allergy and immunology: A quantitative real-time polymerase chain reaction method for diagnosing asthma and asthma exacerbation.过敏与免疫学领域的近期专利：一种用于诊断哮喘和哮喘加重的定量实时聚合酶链反应方法。
Clin Transl Allergy. 2022 Mar 31;12(4):e12136. doi: 10.1002/clt2.12136. eCollection 2022 Apr.
6
A neutrophil subset defined by intracellular olfactomedin 4 is associated with mortality in sepsis.一种由细胞内嗅觉素 4 定义的中性粒细胞亚群与脓毒症患者的死亡率相关。
Am J Physiol Lung Cell Mol Physiol. 2021 May 1;320(5):L892-L902. doi: 10.1152/ajplung.00090.2020. Epub 2020 Dec 23.
7
Serum Calprotectin Is a Potential Marker in Patients with Asthma.血清钙卫蛋白可能是哮喘患者的标志物。
J Korean Med Sci. 2020 Nov 9;35(43):e362. doi: 10.3346/jkms.2020.35.e362.
8
Augmented angiogenic transcription factor, SOX18, is associated with asthma exacerbation.增强的血管生成转录因子 SOX18 与哮喘加重有关。
J Asthma. 2021 Sep;58(9):1143-1154. doi: 10.1080/02770903.2020.1771727. Epub 2020 May 27.
9
Serum levels of olfactomedin 4: a biomarker for asthma control state in asthmatics.嗅觉介素4的血清水平：哮喘患者哮喘控制状态的生物标志物
Ann Transl Med. 2020 Apr;8(7):494. doi: 10.21037/atm.2020.03.213.
10
Predictive Value of Novel Inflammation-Based Biomarkers for Pulmonary Hypertension in the Acute Exacerbation of Chronic Obstructive Pulmonary Disease.新型炎症标志物对慢性阻塞性肺疾病急性加重期肺动脉高压的预测价值。
Anal Cell Pathol (Amst). 2019 Oct 14;2019:5189165. doi: 10.1155/2019/5189165. eCollection 2019.
Zotero 插件